Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion

被引:49
|
作者
Wang, EX
Sun, X
Qian, Y
Zhao, LQ
Tien, P
Gao, GF
机构
[1] Chinese Acad Sci, Inst Microbiol, Dept Mol Virol & Bioengn, Beijing 100080, Peoples R China
[2] Capital Inst Pediat, Beijing Municipal Lab Infect & Immun, Beijing 100020, Peoples R China
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
关键词
human respiratory syncytial virus; hRSV; virus fusion; fusion (F) protein; coiled coil; heptad repeats; inhibition;
D O I
10.1016/S0006-291X(03)00197-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heptad repeat regions (HR1 and HR2) are highly conserved peptides located in F-1 of paramyxovirus envelope proteins. They are important in the process of virus fusion and form six-helix bundle structure (trimer of HR1 and HR2 heterodimer) post-fusion, similar to those found in the fusion proteins of other enveloped viruses, such as retrovirus HIV. Both HR1 and HR2 show potent inhibition for virus fusion in some members of paramyxovirus. However, in other members, only HR2 gives strong inhibition whereas HR1 does not. Human respiratory syncytial virus (hRSV) is a member of paramyxovirus and its crystal structure of HR1 and HR2 six-helix bundle was solved lately. Although hRSV HR2 inhibition was reported, nevertheless the effect of HR1 on virus fusion is not known. In this study, hRSV HR1 and HR2 were expressed as fusion protein separately in Escherichia coli system and their complex assembly and virus fusion inhibition effect have been analysed. It shows that both HR1 and HR2 (in the fusion form with 50-amino-acid fusion partner) of hRSV F protein give strong inhibition on virus fusion (IC50 values are 1.68 and 2.93 muM, respectively) and they form stable six-helix bundle in vitro with both in the fusion protein form. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 50 条
  • [11] Structural characterization of the human respiratory syncytial virus fusion protein core
    Zhao, X
    Singh, M
    Malashkevich, VN
    Kim, PS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) : 14172 - 14177
  • [12] MAPPING OF A FUSION RELATED EPITOPE OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN
    PARADISO, PR
    HU, BT
    ARUMUGHAM, R
    HILDRETH, S
    VACCINE, 1991, 9 (04) : 231 - 237
  • [13] Modelling the structure of the fusion protein from human respiratory syncytial virus
    Smith, BJ
    Lawrence, MC
    Colman, PM
    PROTEIN ENGINEERING, 2002, 15 (05): : 365 - 371
  • [14] Genetic Characterization of Fusion Protein of Human Respiratory Syncytial Virus: Beijing
    Qi Lu
    Chun-xia Zhao
    Kun-ling Shen
    Wen-bo Xu
    Yan Zhang
    Jia-lin Yu
    Xi-qiang Yang
    Infection International(Electronic Edition), 2012, 1 (02) : 74 - 79
  • [15] Expression and purification of human respiratory syncytial virus recombinant fusion protein
    Arcuri, Helen A.
    Apponi, Luciano H.
    Valentini, Sandro R.
    Durigon, Edison L.
    de Azevedo, Walter F.
    Fossey, Marcelo A.
    Rahal, Paula
    de Souza, Fatima P.
    PROTEIN EXPRESSION AND PURIFICATION, 2008, 62 (02) : 146 - 152
  • [16] Identification of Residues in the Human Respiratory Syncytial Virus Fusion Protein That Modulate Fusion Activity and Pathogenesis
    Hotard, Anne L.
    Lee, Sujin
    Currier, Michael G.
    Crowe, James E., Jr.
    Sakamoto, Kaori
    Newcomb, Dawn C.
    Peebles, R. Stokes, Jr.
    Plemper, Richard K.
    Moore, Martin L.
    JOURNAL OF VIROLOGY, 2015, 89 (01) : 512 - 522
  • [17] Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity
    Martin, Diana
    Calder, Lesley J.
    Garcia-Barreno, Blanca
    Skehel, John J.
    Melero, Jose A.
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 1649 - 1658
  • [18] Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection
    Bonfanti, Jean-Francois
    Roymans, Dirk
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 479 - 487
  • [19] Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors
    Feng, Song
    Li, Chao
    Chen, Dongdong
    Zheng, Xiufang
    Yun, Hongying
    Gao, Lu
    Shen, Hong C.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 1147 - 1157
  • [20] PURIFICATION AND CHARACTERIZATION OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN
    WALSH, EE
    BRANDRISS, MW
    SCHLESINGER, JJ
    JOURNAL OF GENERAL VIROLOGY, 1985, 66 (MAR): : 409 - 415